Thursday
August 1
2019

‘Biotech R&D Makes India Hub of Quality Drugs, Vaccines’: Trevor Mundel of Gates Foundation

By Sanchita Sharma

Trevor Mundel is the president of Global Health at the Bill & Melinda Gates Foundation and leads the Foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in low- and middle-income countries. He also manages cross-cutting product development programmes, including discovery & translational sciences, innovative technology solutions, and vaccine development in close collaboration with an international network of grantees, partners and governments.

In India to deliver a talk on Innovating for impact: How India can solve some of the world’s toughest health challenges at the All-India Institute of Medical Sciences on Monday, he speaks to Sanchita Sharma on India’s leadership in developing high quality, safe and effective vaccines and drugs and its potential to offer digital global health solutions.

Photo courtesy of Keoni Cabral.

Source: Hindustan Times (link opens in a new window)

Categories
Health Care, Technology
Tags
Bill & Melinda Gates Foundation, emerging markets, global development, global health, LMICs, vaccines